Samsung partners with BrickBio to pioneer advanced molecules and therapies using protein engineering for ADCs

CAR-T Digest - August 2020

18 Mar 2024: Samsung partners with BrickBio to pioneer advanced molecules and therapies using protein engineering for ADCs

Samsung Ventures backs BrickBio, a preclinical-stage biopharmaceutical startup in its early stages
The investment will fuel BrickBio’s efforts in refining its protein engineering tech and advancing its experimental treatments
Samsung will explore, produce, and enhance advanced therapies using BrickBio’s unique protein engineering methods
BrickBio employs an expanded genetic code to integrate synthetic amino acids into proteins within living cells, fostering the development of precision biologics
BrickBio’s creative engine is churning out potential solutions for various diseases, bringing hope for better treatments